Clinical Trials Directory

Trials / Conditions / Anaplastic Lymphoma Kinase

Anaplastic Lymphoma Kinase

3 registered clinical trials studyying Anaplastic Lymphoma Kinase — 2 currently recruiting.

StatusTrialSponsorPhase
RecruitingA Study of Alectinib and Duvelisib in People With Anaplastic Lymphoma Kinase-Positive Anaplastic Large Cell Ly
NCT07001384
Memorial Sloan Kettering Cancer CenterPhase 1
CompletedA Study of Brigatinib to Treat Adults With Anaplastic Lymphoma Kinase (ALK) Positive Metastatic Non Small Cell
NCT04887519
Takeda—
RecruitingA Study of Usage of Brigatinib in the Treatment of Adult Participants for Approved Indications In South Korea
NCT04592523
Takeda—